Spazur 5 mg filmom obložene tablete
| Name | Spazur 5 mg filmom obložene tablete |
|---|---|
| Marketing Authorisation Number | HR-H-556294671 |
| Active Substance | solifenacinsukcinat |
| Composition | svaka filmom obložena tableta sadrži 5 mg solifenacinsukcinata, što odgovara 3,8 mg solifenacina |
| Pharmaceutical Form | filmom obložena tableta |
| Manufacturer | Jadran Galenski laboratorij d.d., Rijeka, Hrvatska Genepharm S.A., Pallini Attiki, Grčka |
| Marketing Authorisation Holder | Jadran Galenski laboratorij d.d., Svilno 20, Rijeka, Hrvatska |
| Marketing Authorisation Date | 29.06.2023 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/22-02/165 |
| Registration Number | 381-12-01/154-23-07 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | ponovljivi recept |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | G04BD08 |
| Marketing status | stavljeno u promet |
| Shortage status | nema nestašice |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
